Vanguard Capital Management
HURA

Vanguard Capital Management’s TuHURA Biosciences HURA Stock Holding History

Vanguard Capital Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.31M Buy
2,267,901
+193,673
+9% +$451K ﹤0.01% 3095
2026
Q1 		$3.71M Buy
+2,074,228
New +$2.54M ﹤0.01% 3167

Other funds holding HURA

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management's HURA Position: Q2 2026 in Review

Vanguard Capital Management increased its TuHURA Biosciences (HURA) stake by 9.3% in Q2 2026, buying an estimated $451K and bringing the position to 2,267,901 shares worth $5.31M. The position accounts for ﹤0.01% of the portfolio, ranked #3095.

Vanguard Capital Management first reported a position in HURA in Q1 2026 and has held it in 2 quarters since. 83 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Vanguard Capital Management held 2,267,901 shares of TuHURA Biosciences worth $5.31M as of Q2 2026.
  • Vanguard Capital Management bought 193,673 TuHURA Biosciences shares in Q2 2026, an estimated $451K.
  • TuHURA Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3095 holding.
  • Vanguard Capital Management first reported a position in TuHURA Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 83 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.